Robotic surgery for bladder cancer sparks debate among specialists

A response paper challenges findings from a major multi-hospital study on robot-assisted bladder removal for early-stage cancer patients. The disagreement highlights ongoing questions about when hospitals should adopt expensive robotic procedures and which patients truly benefit—critical issues for health systems weighing surgical technology investments.

Originaltitel: Response to: ‘Comment on long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer’